Hayasa Metals Inc. (TSXV:HAY)

Theseus Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1.07	0.3	0.52	0.14	0.21
Short-Term Investments	-	0.03	0.09	-	0.04
Cash & Short-Term Investments	1.07	0.33	0.61	0.14	0.26
Cash Growth	225.09%	-46.15%	332.91%	-44.68%	-77.31%
Other Receivables	0.12	0.25	0.05	0.05	0.05
Receivables	0.12	0.25	0.05	0.05	0.05
Prepaid Expenses	0.05	0.08	0.01	0.01	0.02
Total Current Assets	1.25	0.67	0.67	0.2	0.33
Property, Plant & Equipment	0.63	0.22	2.55	2.41	2.07
Other Long-Term Assets	0.03	0.08	0.07	0.07	0.12
Total Assets	1.91	0.97	3.29	2.68	2.51
Accounts Payable	0.1	0.13	0.07	0.09	0.16
Accrued Expenses	0.2	0.38	0.26	0.2	0.01
Short-Term Debt	0.1	0.1	-	-	-
Other Current Liabilities	-	0.15	0.11	0.07	0.01
Total Current Liabilities	0.4	0.75	0.44	0.36	0.18
Other Long-Term Liabilities	0.03	0.01	-	-	-
Total Liabilities	0.44	0.76	0.44	0.36	0.18
Common Stock	21.21	18.95	17.79	16.49	15.89
Retained Earnings	-22.24	-21.01	-17.07	-16.08	-15.34
Comprehensive Income & Other	2.5	2.26	2.13	1.91	1.78
Shareholders' Equity	1.47	0.21	2.86	2.33	2.33
Total Liabilities & Equity	1.91	0.97	3.29	2.68	2.51
Total Debt	0.1	0.1	-	-	-
Net Cash (Debt)	0.97	0.23	0.61	0.14	0.26
Net Cash Growth	322.71%	-62.44%	332.91%	-44.68%	-77.31%
Net Cash Per Share	0.02	0.01	0.03	0.01	0.03
Filing Date Shares Outstanding	61.1	58.07	25.87	24.62	14.61
Total Common Shares Outstanding	61.1	37.92	25.87	14.61	12.54
Working Capital	0.84	-0.08	0.23	-0.15	0.15
Book Value Per Share	0.02	0.01	0.11	0.16	0.19
Tangible Book Value	1.47	0.21	2.86	2.33	2.33
Tangible Book Value Per Share	0.02	0.01	0.11	0.16	0.19

Source: S&P Global Market Intelligence. Standard template. Financial Sources.